EBIT at other companies
Other financials
Where this comes from
Calculated from Edgewise Therapeutics, Inc.’s reported figures.
The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edgewise Therapeutics, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edgewise Therapeutics, Inc.'s EBIT?
- Edgewise Therapeutics, Inc. (EWTX) reported EBIT of -$54.12M in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s EBIT changed year-over-year?
- Edgewise Therapeutics, Inc.'s EBIT decreased by 17.7% year-over-year, from -$45.96M to -$54.12M.
- What is the long-term trend for Edgewise Therapeutics, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Edgewise Therapeutics, Inc.'s EBIT has grown at a 45.1% compound annual growth rate (CAGR), from -$43.22M to -$191.41M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.